PHAT vs BIIB: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Biogen Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
$12.61
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | PHAT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.02B | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.9% | -0.1% | PHAT |
| Gross Margin | 87.1% | 78.9% | PHAT |
Analyze PHAT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or BIIB a better investment?
Comparing PHAT and BIIB: Phathom Pharmaceuticals Inc has a market cap of $1.02B while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and BIIB?
PHAT (Phathom Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or BIIB?
PHAT has higher revenue growth at 0.9% vs -0.1% for BIIB.
Which company is more profitable: PHAT or BIIB?
Phathom Pharmaceuticals Inc (PHAT) has higher gross margins at 87.1% compared to 78.9% for BIIB.
Which is the larger company: PHAT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $1.02B for PHAT.
Should I buy PHAT or BIIB in 2026?
Both PHAT and BIIB have investment merit. PHAT trades at $12.61 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and BIIB stock?
Key differences: Market Cap ($1.02B vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.9% vs -0.1%), Gross Margin (87.1% vs 78.9%).